TY - JOUR
T1 - Scratching behavior does not necessarily correlate with epidermal nerve fiber sprouting or inflammatory cell infiltration
AU - Kido, Makiko
AU - Takeuchi, Satoshi
AU - Esaki, Hitokazu
AU - Hayashida, Sayaka
AU - Furue, Masutaka
N1 - Funding Information:
The authors would like to thank Japan Energy Co., Kowa Co. Ltd., and Astellas Pharma Inc. for kindly providing CX659S and FK506, respectively. This work was supported by Health Science Research Grants from the Ministry of Health, Welfare and Labor , and from the Ministry of Education, Culture, Sports, Science and Technology of Japan .
PY - 2010/5
Y1 - 2010/5
N2 - Background: Increased sprouting of epidermal nerve fibers of lesional skin are thought to be associated with persistent pruritus in chronic inflammatory dermatitis such as atopic dermatitis as supported by a murine study using tacrolimus (or FK506: FK) which was shown to inhibit both epidermal sprouting of nerves and scratching behavior or by immunohistochemical observations of lesional skin in the patients with atopic dermatitis or prurigo, etc. Objectives: To examine a mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 (MEK1/2) inhibitor (CX-659S: CX) for a possible anti-pruritic property in vivo since some MEK1/2 inhibitors have been reported to inhibit neurite growth in vitro. Methods: CX, FK and corticosteroids (betamethasone valerate: BV) were topically applied on inflamed skin in a mouse model of chronic dermatitis using repetitive hapten painting to examine anti-pruritic property and anti-inflammatory effects. Scratching behaviors were assessed using MicroAct automatic measuring system, and epidermal sprouting of nerves and skin inflammation was assessed histologically. Results: FK significantly decrease scratching behavior, but CX and BV failed to do so despite of their ability to significantly inhibit epidermal nerve fiber sprouting and skin inflammation, respectively. In addition, CX. +. BV mixture synergistically inhibited epidermal nerve fiber sprouting and skin inflammation even more potently than FK without decreasing scratching behavior. Conclusions: These findings suggest that the scratching behavior does not necessarily correlate with epidermal nerve fiber sprouting or inflammatory cell infiltration.
AB - Background: Increased sprouting of epidermal nerve fibers of lesional skin are thought to be associated with persistent pruritus in chronic inflammatory dermatitis such as atopic dermatitis as supported by a murine study using tacrolimus (or FK506: FK) which was shown to inhibit both epidermal sprouting of nerves and scratching behavior or by immunohistochemical observations of lesional skin in the patients with atopic dermatitis or prurigo, etc. Objectives: To examine a mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 (MEK1/2) inhibitor (CX-659S: CX) for a possible anti-pruritic property in vivo since some MEK1/2 inhibitors have been reported to inhibit neurite growth in vitro. Methods: CX, FK and corticosteroids (betamethasone valerate: BV) were topically applied on inflamed skin in a mouse model of chronic dermatitis using repetitive hapten painting to examine anti-pruritic property and anti-inflammatory effects. Scratching behaviors were assessed using MicroAct automatic measuring system, and epidermal sprouting of nerves and skin inflammation was assessed histologically. Results: FK significantly decrease scratching behavior, but CX and BV failed to do so despite of their ability to significantly inhibit epidermal nerve fiber sprouting and skin inflammation, respectively. In addition, CX. +. BV mixture synergistically inhibited epidermal nerve fiber sprouting and skin inflammation even more potently than FK without decreasing scratching behavior. Conclusions: These findings suggest that the scratching behavior does not necessarily correlate with epidermal nerve fiber sprouting or inflammatory cell infiltration.
UR - http://www.scopus.com/inward/record.url?scp=77952238977&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952238977&partnerID=8YFLogxK
U2 - 10.1016/j.jdermsci.2010.03.007
DO - 10.1016/j.jdermsci.2010.03.007
M3 - Article
C2 - 20399618
AN - SCOPUS:77952238977
SN - 0923-1811
VL - 58
SP - 130
EP - 135
JO - Journal of Dermatological Science
JF - Journal of Dermatological Science
IS - 2
ER -